| Clinical features |
|
|
|
|
| Hypersalivation |
19/21 (90) |
4/4 (100) |
1/2 (50) |
24/27 (88) |
| Agitation |
14/21 (67) |
2/4 (50) |
0/2 (0) |
16/27 (59) |
| Weakness or paralysis |
14/21 (67) |
3/4 (75) |
2/2 (100) |
19/27 (70) |
| Fever |
14/21 (67) |
1/4 (25) |
1/2 (50) |
16/27 (59) |
| Hallucinations |
11/21 (52) |
4/4 (100) |
1/2 (50) |
16/27 (59) |
| Confusion |
12/21 (57) |
0/4 (0) |
1/2 (50) |
13/27 (48) |
| Hydrophobia |
8/21 (38) |
1/4 (25) |
0/2 (0) |
9/27 (33) |
| Alternating lucidity and confusion |
8/21 (38) |
0/4 (0) |
1/2 (50) |
9/27 (33) |
| Aggression |
6/21 (29) |
1/4 (25) |
0/2 (0) |
7/27 (26) |
| Vomiting |
6/21 (29) |
1/4 (25) |
1/2 (50) |
8/27 (30) |
| Spasms |
5/21 (24) |
0/4 (0) |
0/2 (0) |
5/27 (19) |
| Convulsions |
5/21 (24) |
0/4 (0) |
1/2 (50) |
6/27 (22) |
| Abdominal distension |
4/21 (19) |
1/4 (25) |
0/2 (0) |
5/27 (19) |
| Pain at the bite site |
4/21 (19) |
0/4 (0) |
1/2 (50) |
5/27 (19) |
| Diarrhea |
2/21 (10) |
1/4 (25) |
0/2 (0) |
3/27 (11) |
Insomnia
|
2/21 (10)
|
1/4 (25)
|
0/2 (0)
|
3/27 (11)
|
| Laboratory results |
|
|
|
|
| Elevated leukocyte count (>10 x 109 cells/L) |
9/19 (47) |
4/4 (100) |
0/2 (0) |
13/25 (50) |
| Elevated urea (>7 mmol/L) |
11/19 (61) |
2/4 (50) |
0/2 (0) |
13/25 (50) |
| Elevated creatinine (>100 μmol/L) |
1/19 (5) |
1/4 (25) |
0/2 (0) |
2/25 (1) |
| Elevated total bilirubin (>21 μmol/L) |
0/5 (0) |
0/4 (0) |
0/1 (0) |
0/10 (0) |
| Elevated conjugated bilirubin (>6 μmol/L) |
0/5 (0) |
0/4 (0) |
0/1 (0) |
0/10 (0) |
| Elevated alkaline phosphatase (>120 IU/L) |
3/5 (60) |
3/4 (75) |
1/1 (100) |
7/10 (70) |
| Elevated gamma glucosyl transferase (>35 IU/L) |
2/5 (40) |
0/4 (0) |
0/1 (0) |
2/10 (20) |
| Elevated alanine transaminase (>40 IU/L) |
1/5 (20) |
2/4 (50) |
0/1 (0) |
3/10 (30) |
| Elevated aspartate transaminase (>40 IU/L) |
2/5 (40) |
2/4 (50) |
0/1 (0) |
4/10 (40) |
